Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Human Immunology
|
May 4, 2005
Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura
Feng Jin, Joseph P Balthasar
International Journal of Pharmaceutics
|
September 21, 2005
Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia
Rong Deng, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
November 28, 2012
Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer
Lubna Abuqayyas, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
January 24, 2007
Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia
Rong Deng, Joseph P Balthasar
The AAPS Journal
|
September 8, 2012
Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn
Yang Chen, Joseph P Balthasar
Cancer Biology & Medicine
|
April 17, 2014
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
Patrick M Glassman, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
July 29, 2003
Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice
Evelyn D Lobo, Joseph P Balthasar
International Journal of Pharmaceutics
|
February 11, 2014
PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice
Dhaval K Shah, Joseph P Balthasar
Clinical Laboratory
|
April 13, 2004
Mechanisms of IVIG action in immune thrombocytopenic purpura
Ryan J Hansen, Joseph P Balthasar
Journal of Immunoassay & Immunochemistry
|
November 24, 2004
Development and validation of enzyme-linked immunosorbent assays for quantification of anti-methotrexate IgG and Fab in mouse and rat plasma
Zia R Tayab, Joseph P Balthasar
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Human Immunology
|
May 4, 2005
Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura
Feng Jin, Joseph P Balthasar
International Journal of Pharmaceutics
|
September 21, 2005
Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia
Rong Deng, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
November 28, 2012
Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer
Lubna Abuqayyas, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
January 24, 2007
Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia
Rong Deng, Joseph P Balthasar
The AAPS Journal
|
September 8, 2012
Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn
Yang Chen, Joseph P Balthasar
Cancer Biology & Medicine
|
April 17, 2014
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy
Patrick M Glassman, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
July 29, 2003
Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice
Evelyn D Lobo, Joseph P Balthasar
International Journal of Pharmaceutics
|
February 11, 2014
PK/TD modeling for prediction of the effects of 8C2, an anti-topotecan mAb, on topotecan-induced toxicity in mice
Dhaval K Shah, Joseph P Balthasar
Clinical Laboratory
|
April 13, 2004
Mechanisms of IVIG action in immune thrombocytopenic purpura
Ryan J Hansen, Joseph P Balthasar
Journal of Immunoassay & Immunochemistry
|
November 24, 2004
Development and validation of enzyme-linked immunosorbent assays for quantification of anti-methotrexate IgG and Fab in mouse and rat plasma
Zia R Tayab, Joseph P Balthasar
Page
of 9